Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Brigatinib Tablet Market Growth 2022-2028

  • LP 4817867
  • 78 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Brigatinib Tablet will have significant change from previous year. According to our (LP Information) latest study, the global Brigatinib Tablet market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Brigatinib Tablet market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Brigatinib Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Brigatinib Tablet market, reaching US$ million by the year 2028. As for the Europe Brigatinib Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Brigatinib Tablet players cover ARIAD Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Brigatinib Tablet market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

30mg

50mg

180mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

ARIAD Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Brigatinib Tablet Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Brigatinib Tablet by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Brigatinib Tablet by Country/Region, 2017, 2022 & 2028

2.2 Brigatinib Tablet Segment by Type

2.2.1 30mg

2.2.2 50mg

2.2.3 180mg

2.3 Brigatinib Tablet Sales by Type

2.3.1 Global Brigatinib Tablet Sales Market Share by Type (2017-2022)

2.3.2 Global Brigatinib Tablet Revenue and Market Share by Type (2017-2022)

2.3.3 Global Brigatinib Tablet Sale Price by Type (2017-2022)

2.4 Brigatinib Tablet Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.5 Brigatinib Tablet Sales by Application

2.5.1 Global Brigatinib Tablet Sale Market Share by Application (2017-2022)

2.5.2 Global Brigatinib Tablet Revenue and Market Share by Application (2017-2022)

2.5.3 Global Brigatinib Tablet Sale Price by Application (2017-2022)

3 Global Brigatinib Tablet by Company

3.1 Global Brigatinib Tablet Breakdown Data by Company

3.1.1 Global Brigatinib Tablet Annual Sales by Company (2020-2022)

3.1.2 Global Brigatinib Tablet Sales Market Share by Company (2020-2022)

3.2 Global Brigatinib Tablet Annual Revenue by Company (2020-2022)

3.2.1 Global Brigatinib Tablet Revenue by Company (2020-2022)

3.2.2 Global Brigatinib Tablet Revenue Market Share by Company (2020-2022)

3.3 Global Brigatinib Tablet Sale Price by Company

3.4 Key Manufacturers Brigatinib Tablet Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Brigatinib Tablet Product Location Distribution

3.4.2 Players Brigatinib Tablet Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Brigatinib Tablet by Geographic Region

4.1 World Historic Brigatinib Tablet Market Size by Geographic Region (2017-2022)

4.1.1 Global Brigatinib Tablet Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Brigatinib Tablet Annual Revenue by Geographic Region

4.2 World Historic Brigatinib Tablet Market Size by Country/Region (2017-2022)

4.2.1 Global Brigatinib Tablet Annual Sales by Country/Region (2017-2022)

4.2.2 Global Brigatinib Tablet Annual Revenue by Country/Region

4.3 Americas Brigatinib Tablet Sales Growth

4.4 APAC Brigatinib Tablet Sales Growth

4.5 Europe Brigatinib Tablet Sales Growth

4.6 Middle East & Africa Brigatinib Tablet Sales Growth

5 Americas

5.1 Americas Brigatinib Tablet Sales by Country

5.1.1 Americas Brigatinib Tablet Sales by Country (2017-2022)

5.1.2 Americas Brigatinib Tablet Revenue by Country (2017-2022)

5.2 Americas Brigatinib Tablet Sales by Type

5.3 Americas Brigatinib Tablet Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Brigatinib Tablet Sales by Region

6.1.1 APAC Brigatinib Tablet Sales by Region (2017-2022)

6.1.2 APAC Brigatinib Tablet Revenue by Region (2017-2022)

6.2 APAC Brigatinib Tablet Sales by Type

6.3 APAC Brigatinib Tablet Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Brigatinib Tablet by Country

7.1.1 Europe Brigatinib Tablet Sales by Country (2017-2022)

7.1.2 Europe Brigatinib Tablet Revenue by Country (2017-2022)

7.2 Europe Brigatinib Tablet Sales by Type

7.3 Europe Brigatinib Tablet Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Brigatinib Tablet by Country

8.1.1 Middle East & Africa Brigatinib Tablet Sales by Country (2017-2022)

8.1.2 Middle East & Africa Brigatinib Tablet Revenue by Country (2017-2022)

8.2 Middle East & Africa Brigatinib Tablet Sales by Type

8.3 Middle East & Africa Brigatinib Tablet Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Brigatinib Tablet

10.3 Manufacturing Process Analysis of Brigatinib Tablet

10.4 Industry Chain Structure of Brigatinib Tablet

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Brigatinib Tablet Distributors

11.3 Brigatinib Tablet Customer

12 World Forecast Review for Brigatinib Tablet by Geographic Region

12.1 Global Brigatinib Tablet Market Size Forecast by Region

12.1.1 Global Brigatinib Tablet Forecast by Region (2023-2028)

12.1.2 Global Brigatinib Tablet Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Brigatinib Tablet Forecast by Type

12.7 Global Brigatinib Tablet Forecast by Application

13 Key Players Analysis

13.1 ARIAD Pharmaceuticals

13.1.1 ARIAD Pharmaceuticals Company Information

13.1.2 ARIAD Pharmaceuticals Brigatinib Tablet Product Offered

13.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 ARIAD Pharmaceuticals Main Business Overview

13.1.5 ARIAD Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Brigatinib Tablet Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Brigatinib Tablet Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 30mg

Table 4. Major Players of 50mg

Table 5. Major Players of 180mg

Table 6. Global Brigatinib Tablet Sales by Type (2017-2022) & (K MT)

Table 7. Global Brigatinib Tablet Sales Market Share by Type (2017-2022)

Table 8. Global Brigatinib Tablet Revenue by Type (2017-2022) & ($ million)

Table 9. Global Brigatinib Tablet Revenue Market Share by Type (2017-2022)

Table 10. Global Brigatinib Tablet Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Brigatinib Tablet Sales by Application (2017-2022) & (K MT)

Table 12. Global Brigatinib Tablet Sales Market Share by Application (2017-2022)

Table 13. Global Brigatinib Tablet Revenue by Application (2017-2022)

Table 14. Global Brigatinib Tablet Revenue Market Share by Application (2017-2022)

Table 15. Global Brigatinib Tablet Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Brigatinib Tablet Sales by Company (2020-2022) & (K MT)

Table 17. Global Brigatinib Tablet Sales Market Share by Company (2020-2022)

Table 18. Global Brigatinib Tablet Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Brigatinib Tablet Revenue Market Share by Company (2020-2022)

Table 20. Global Brigatinib Tablet Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Brigatinib Tablet Producing Area Distribution and Sales Area

Table 22. Players Brigatinib Tablet Products Offered

Table 23. Brigatinib Tablet Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Brigatinib Tablet Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Brigatinib Tablet Sales Market Share Geographic Region (2017-2022)

Table 28. Global Brigatinib Tablet Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Brigatinib Tablet Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Brigatinib Tablet Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Brigatinib Tablet Sales Market Share by Country/Region (2017-2022)

Table 32. Global Brigatinib Tablet Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Brigatinib Tablet Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Brigatinib Tablet Sales by Country (2017-2022) & (K MT)

Table 35. Americas Brigatinib Tablet Sales Market Share by Country (2017-2022)

Table 36. Americas Brigatinib Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Brigatinib Tablet Revenue Market Share by Country (2017-2022)

Table 38. Americas Brigatinib Tablet Sales by Type (2017-2022) & (K MT)

Table 39. Americas Brigatinib Tablet Sales Market Share by Type (2017-2022)

Table 40. Americas Brigatinib Tablet Sales by Application (2017-2022) & (K MT)

Table 41. Americas Brigatinib Tablet Sales Market Share by Application (2017-2022)

Table 42. APAC Brigatinib Tablet Sales by Region (2017-2022) & (K MT)

Table 43. APAC Brigatinib Tablet Sales Market Share by Region (2017-2022)

Table 44. APAC Brigatinib Tablet Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Brigatinib Tablet Revenue Market Share by Region (2017-2022)

Table 46. APAC Brigatinib Tablet Sales by Type (2017-2022) & (K MT)

Table 47. APAC Brigatinib Tablet Sales Market Share by Type (2017-2022)

Table 48. APAC Brigatinib Tablet Sales by Application (2017-2022) & (K MT)

Table 49. APAC Brigatinib Tablet Sales Market Share by Application (2017-2022)

Table 50. Europe Brigatinib Tablet Sales by Country (2017-2022) & (K MT)

Table 51. Europe Brigatinib Tablet Sales Market Share by Country (2017-2022)

Table 52. Europe Brigatinib Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Brigatinib Tablet Revenue Market Share by Country (2017-2022)

Table 54. Europe Brigatinib Tablet Sales by Type (2017-2022) & (K MT)

Table 55. Europe Brigatinib Tablet Sales Market Share by Type (2017-2022)

Table 56. Europe Brigatinib Tablet Sales by Application (2017-2022) & (K MT)

Table 57. Europe Brigatinib Tablet Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Brigatinib Tablet Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Brigatinib Tablet Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Brigatinib Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Brigatinib Tablet Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Brigatinib Tablet Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Brigatinib Tablet Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Brigatinib Tablet Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Brigatinib Tablet Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Brigatinib Tablet

Table 67. Key Market Challenges & Risks of Brigatinib Tablet

Table 68. Key Industry Trends of Brigatinib Tablet

Table 69. Brigatinib Tablet Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Brigatinib Tablet Distributors List

Table 72. Brigatinib Tablet Customer List

Table 73. Global Brigatinib Tablet Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Brigatinib Tablet Sales Market Forecast by Region

Table 75. Global Brigatinib Tablet Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Brigatinib Tablet Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Brigatinib Tablet Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Brigatinib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Brigatinib Tablet Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Brigatinib Tablet Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Brigatinib Tablet Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Brigatinib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Brigatinib Tablet Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Brigatinib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Brigatinib Tablet Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Brigatinib Tablet Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Brigatinib Tablet Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Brigatinib Tablet Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Brigatinib Tablet Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Brigatinib Tablet Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Brigatinib Tablet Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Brigatinib Tablet Revenue Market Share Forecast by Application (2023-2028)

Table 93. ARIAD Pharmaceuticals Basic Information, Brigatinib Tablet Manufacturing Base, Sales Area and Its Competitors

Table 94. ARIAD Pharmaceuticals Brigatinib Tablet Product Offered

Table 95. ARIAD Pharmaceuticals Brigatinib Tablet Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. ARIAD Pharmaceuticals Main Business

Table 97. ARIAD Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Brigatinib Tablet

Figure 2. Brigatinib Tablet Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Brigatinib Tablet Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Brigatinib Tablet Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Brigatinib Tablet Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 30mg

Figure 10. Product Picture of 50mg

Figure 11. Product Picture of 180mg

Figure 12. Global Brigatinib Tablet Sales Market Share by Type in 2021

Figure 13. Global Brigatinib Tablet Revenue Market Share by Type (2017-2022)

Figure 14. Brigatinib Tablet Consumed in Hospital

Figure 15. Global Brigatinib Tablet Market: Hospital (2017-2022) & (K MT)

Figure 16. Brigatinib Tablet Consumed in Pharmacy

Figure 17. Global Brigatinib Tablet Market: Pharmacy (2017-2022) & (K MT)

Figure 18. Global Brigatinib Tablet Sales Market Share by Application (2017-2022)

Figure 19. Global Brigatinib Tablet Revenue Market Share by Application in 2021

Figure 20. Brigatinib Tablet Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Brigatinib Tablet Revenue Market Share by Company in 2021

Figure 22. Global Brigatinib Tablet Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Brigatinib Tablet Revenue Market Share by Geographic Region in 2021

Figure 24. Global Brigatinib Tablet Sales Market Share by Region (2017-2022)

Figure 25. Global Brigatinib Tablet Revenue Market Share by Country/Region in 2021

Figure 26. Americas Brigatinib Tablet Sales 2017-2022 (K MT)

Figure 27. Americas Brigatinib Tablet Revenue 2017-2022 ($ Millions)

Figure 28. APAC Brigatinib Tablet Sales 2017-2022 (K MT)

Figure 29. APAC Brigatinib Tablet Revenue 2017-2022 ($ Millions)

Figure 30. Europe Brigatinib Tablet Sales 2017-2022 (K MT)

Figure 31. Europe Brigatinib Tablet Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Brigatinib Tablet Sales 2017-2022 (K MT)

Figure 33. Middle East & Africa Brigatinib Tablet Revenue 2017-2022 ($ Millions)

Figure 34. Americas Brigatinib Tablet Sales Market Share by Country in 2021

Figure 35. Americas Brigatinib Tablet Revenue Market Share by Country in 2021

Figure 36. United States Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Brigatinib Tablet Sales Market Share by Region in 2021

Figure 41. APAC Brigatinib Tablet Revenue Market Share by Regions in 2021

Figure 42. China Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Brigatinib Tablet Sales Market Share by Country in 2021

Figure 49. Europe Brigatinib Tablet Revenue Market Share by Country in 2021

Figure 50. Germany Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Brigatinib Tablet Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Brigatinib Tablet Revenue Market Share by Country in 2021

Figure 57. Egypt Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Brigatinib Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Brigatinib Tablet in 2021

Figure 63. Manufacturing Process Analysis of Brigatinib Tablet

Figure 64. Industry Chain Structure of Brigatinib Tablet

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390